Iga Świątek’s nightmare appears over, with the World Anti-Doping Agency (WADA) concluding that there is "no reasonable basis" to extend her ban.
The 23-year-old tested positive for heart medication trimetazidine (TMZ) in August last year, found by the International Tennis Integrity Agency (ITIA) to have been caused by contamination.
Świątek copped a four-week suspension which ended on December 4.
Click here to watch live tennis on Stan Sport.
However, despite WADA analysing the case and attempting to find sufficient evidence for a longer ban, the governing body will not push ahead.
WADA confirmed "it will not lodge an appeal to the Court of Arbitration for Sport", meaning the world No.2 has clarity around her future.
“WADA’s scientific experts have confirmed the specific contaminated melatonin scenario, as presented by the athlete and accepted by the ITIA, is plausible and that there would be no scientific grounds to challenge it at CAS," the first part of the statement read.
"WADA sought advice from external legal counsel, who considered the athlete's contamination explanation was well evidenced, that the ITIA decision was compliant with the World Anti-Doping Code, and that there was no reasonable basis to appeal it to the CAS."
As the news dropped, Świątek was out on Rod Laver Arena dispatching Germany’s Eva Lys 6-0 6-1.
The five-time major champion spoke about feeling relieved after her fourth-round victory.
"I'm just satisfied I can get a closure, kind of, and I can just move on and finish this whole process," said Świątek.
"I just want to play tennis and focus on the tournament. It's good that the process is over."
The Polish ace will play No.8 seed Emma Navarro in the quarter-finals.
Brought to you by HEAD, Your Game Is Their Game. Find all the latest HEAD tennis, padel, pickleball and squash products now at www.head.com
Comentarios